A detailed history of Versant Capital Management, Inc transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 12 shares of SLP stock, worth $356. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 12 -0.0%
Holding current value
$356
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$33.36 - $45.71 $467 - $639
-14 Reduced 53.85%
12 $0
Q4 2022

Jan 25, 2023

SELL
$36.55 - $51.15 $1,608 - $2,250
-44 Reduced 62.86%
26 $0
Q3 2022

Dec 30, 2022

BUY
$47.75 - $66.88 $2,101 - $2,942
44 Added 169.23%
70 $3,000
Q1 2022

Apr 29, 2022

BUY
$36.56 - $50.98 $950 - $1,325
26 New
26 $1,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $603M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.